Laurion Capital Management’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-126,541
| Closed | -$564K | – | 334 |
|
|
2024
Q2 | $564K | Sell |
126,541
-275,656
| -69% | -$1.23M | 0.01% | 236 |
|
|
2024
Q1 | $3.08M | Sell |
402,197
-155,132
| -28% | -$1.19M | 0.03% | 150 |
|
|
2023
Q4 | $2.37M | Sell |
557,329
-120,000
| -18% | -$511K | 0.02% | 102 |
|
|
2023
Q3 | $2.84M | Buy |
677,329
+426,961
| +171% | +$1.79M | 0.02% | 108 |
|
|
2023
Q2 | $1.39M | Sell |
250,368
-21,432
| -8% | -$119K | 0.01% | 118 |
|
|
2023
Q1 | $1.56M | Hold |
271,800
| – | – | 0.01% | 112 |
|
|
2022
Q4 | $285K | Hold |
271,800
| – | – | ﹤0.01% | 173 |
|
|
2022
Q3 | $728K | Hold |
271,800
| – | – | ﹤0.01% | 175 |
|
|
2022
Q2 | $1.3M | Buy |
271,800
+261,800
| +2,618% | +$1.25M | 0.02% | 146 |
|
|
2022
Q1 | $41K | Sell |
10,000
-3,390
| -25% | -$13.9K | ﹤0.01% | 388 |
|
|
2021
Q4 | $91K | Sell |
13,390
-57,310
| -81% | -$389K | ﹤0.01% | 342 |
|
|
2021
Q3 | $819K | Buy |
+70,700
| New | +$819K | ﹤0.01% | 287 |
|
|
2021
Q2 | – | Sell |
-10,250
| Closed | -$203K | – | 578 |
|
|
2021
Q1 | $203K | Hold |
10,250
| – | – | ﹤0.01% | 476 |
|
|
2020
Q4 | $212K | Hold |
10,250
| – | – | ﹤0.01% | 379 |
|
|
2020
Q3 | $269K | Buy |
+10,250
| New | +$269K | ﹤0.01% | 511 |
|